NOXO Appetite Control Balm™ is to be used in conjunction with any and all diets plans. It strengthens willpower and minimizes cravings assuring successful dieting. Developed by Dr. V. Ruth Pinney, Director of Research and a corporate director at Olfactory Biosciences Corp.
PHILADELPHIA, PA / ACCESSWIRE / Olfactory Biosciences Corp. (OTC: OLFC) is pleased to announce today, new NOXO Appetite Control ™ just in time for the holidays, and which stands ready to come to the rescue of millions of Americans struggling on a diet plan to shed those unwanted pounds. Adding the new balm to your present diet results in a faster and easier weight loss.
The balm is applied topically under the nose and the unique natural ingredients target the body’s olfactory receptors in the nose and signals the brain that the stomach is full. This results in increased effectiveness for all popular diets plans or a basic low calorie such as is available from the government. http://www.nhlbi.nih.gov/health/public/heart/obesity/lose_wt/tac_1600.htm.
From Nutrisystem to Weight Watchers and everything in between, NOXO Appetite Control ™ is like an insurance program curbing the cravings and minimizing impulse eating. www.noxoinfo.com/appetite
According to Dr. Gary Foster, Clinical Director of the University of Pennsylvania’s Weight and Eating Disorder Program, nearly 65% of dieters return to their pre-diet weight after one year. The statistics for crash dieters are even worse according to Wellsphere, a website sponsored by Stanford University. Only 5% of people who lose weight on crash diet will keep that weight off.
Now there is an affordable, effective way to make your diet a success and maintain weight loss over the long term. For more information about NOXO Appetite Control ™ and order information, go online at http://www.noxoinfo.com/appetite
About Olfactory Biosciences Corp.
Olfactory Biosciences Corp.'s NOXO division is focused to develop a variety of products targeting Olfactory Receptors in the nose for the desired effect. These alternative medicine wellness products can modify behavior or provide relief to common behavior challenges such as anxiety, sleeping or weight control, as examples. http://www.noxoinfo.com/investor
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements by the Company, statements regarding the NOXO product line, optimism related to the business, expanding ales and other statements in this press release are forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Such statements are based on current expectations, estimates and projections about the Company's business. Words such as expects, anticipates, intends, plans, believes, sees, estimates and variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks and uncertainties that are difficult to predict. Actual results could vary materially from the description contained herein due to many factors including continued market acceptance of the Company's products or the need to raise additional capital. In addition, actual results could vary materially based on changes or slower growth in the indoor garden market; the potential inability to realize expected benefits and synergies; domestic and international business and economic conditions; changes in customer demand or ordering patterns; changes in the competitive environment including pricing pressures or technological changes; technological advances; shortages of manufacturing capacity; future production variables impacting excess inventory and other risk factors listed from time to time in the Company's Securities and Exchange Commission (SEC) filings under "risk factors" and elsewhere. The forward-looking statements contained in this press release speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this press release.
Richard Stevenson, President
Olfactory Biosciences Corp.
333 E. Lancaster Ave. Suite 317
Wynnewood, PA 19096, USA
Source: Olfactory Biosciences Corp.
Leave a comment...